CD274 and cancer: • We propose to revise the “Cancer immunoediting” concept to take into consideration the migratory behavior of anti-tumoral T cells, to achieve a comprehensive   view of TRM and recirculating memory T cell response to solid cancers before and after anti-PD-1/PD-L1 mAb treatment.